Sofinnova Investments, Inc. Amicus Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$8.86 - $15.69 $4.66 Million - $8.25 Million	-525,530 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$6.63 - $11.16 $332,826 - $560,232	50,200 Added 10.56%	525,530 $4.86 Million
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $1.85 Million - $2.66 Million	-247,644 Reduced 34.25%	475,330 $4.63 Million
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $1.12 Million - $1.85 Million	139,665 Added 23.94%	722,974 $5.8 Million
Q2 2019 Aug 13, 2019	SELL	$10.96 - $14.4 $8,757 - $11,505	-799 Reduced 0.14%	583,309 $7.28 Million
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $908,901 - $1.26 Million	-90,528 Reduced 13.42%	584,108 $7.94 Million
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $1.92 Million - $3.07 Million	228,667 Added 51.27%	674,636 $6.46 Million
Q3 2018 Nov 15, 2018	BUY	$11.6 - $16.54 $5.17 Million - $7.38 Million	445,969 New	445,969 $5.39 Million

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.78B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.